Skip to content
Home/Companies/MedTech/Novacyt
Novacyt

Novacyt

MedTech·France·Exited 2020·Held 1yr
Entry
2019
Hold
1yr
Exit
2020

Who owns Novacyt?

Novacyt has Claret Capital Partners on file as a lender through Harbert European Growth Capital Fund II (2018 vintage), financing since 2019. Its equity owner is not tracked by GP Intel yet.

Hand-verified · updated 2026-05-29

Claret Capital Partners
Investor
Claret Capital Partners
Harbert European Growth Capital Fund II · 2018 · Private Debt

Key facts

HQFrance
SectorMedTech
StatusActive
Websitenovacyt.com
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2020

More from Harbert European Growth Capital Fund II

Other portfolio companies in the same fund.

Butternut Box
Exited
ConsumerUK· 2020
to
Codec.ai
Codec.ai
Exited 2023
Data & AnalyticsIreland· 2020
to
Cubyn
Cubyn
Active
LogisticsFrance· 2020
Paysend
Paysend
Active
FintechUK· 2020
UKCloud
Exited 2022
Cloud InfrastructureUK· 2020
Exoticca
Exoticca
Exited
HospitalitySpain· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Novacyt

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Novacyt?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Novacyt.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue